FBInvestor
Stocks / Lyra Therapeutics Inc
Institutional Ownership

Lyra Therapeutics Inc

CUSIP 55234L204COM NEWLYRAQ1 2026

13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
11.2%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

5 filings · latest Jan 20, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jan 20, 2026Sabby Management, LLC13G9.9%175.2KSEC
2Nov 25, 2025Perceptive Advisors LLC13D/A——SEC
3Nov 18, 2025Perceptive Advisors LLC13D/A5.5%—SEC
4Nov 13, 2025Perceptive Advisors LLC13D/A7.8%—SEC
5Nov 10, 2025Perceptive Advisors LLC13D/A11.2%—SEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Sabby Management, LLC104.1K$51.1K